Document Classification

Section Type: OBJECTIVE

Text: The goal of this study was to examine prospectively the effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin across dose ranges on non-HDL-C, apo B, apo A-I, and total cholesterol (TC) : HDL-C, low-density lipoprotein cholesterol (LDL-C) : HDL-C, non-HDL-C : HDL-C, and apo B : apo A-I ratios in patients with hypercholesterolemia (LDL-C > or = 160 mg/dL and < 250 mg/dL and triglycerides < 400 mg/dL) in the Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin (STELLAR) trial.